Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorides and osteoporosis.

M Kleerekoper1, R Balena

  • 1Department of Medicine, Bone and Mineral Division, Henry Ford Hospital, Detroit, Mich.

Southern Medical Journal
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.

Diabetes, obesity & metabolism·2013
Same author

Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature.

Diabetes, obesity & metabolism·2012
Same author

Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).

Diabetes, obesity & metabolism·2012
Same author

Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.

Diabetic medicine : a journal of the British Diabetic Association·2012
Same author

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.

Diabetic medicine : a journal of the British Diabetic Association·2010
Same author

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2009
Same journal

SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

Southern medical journal·2026
Same journal

Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

Southern medical journal·2026
Same journal

Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

Southern medical journal·2026
Same journal

Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

Southern medical journal·2026
Same journal

Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

Southern medical journal·2026
Same journal

Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

Southern medical journal·2026
See all related articles

Sodium fluoride significantly impacts bone health, offering both benefits and toxicity. Further research into its mechanisms is needed to optimize its use for brittle bone diseases like osteoporosis.

Area of Science:

  • Skeletal biology
  • Pharmacology
  • Bone metabolism

Background:

  • Sodium fluoride is a potent agent affecting the skeleton.
  • Its therapeutic effects are accompanied by potential toxicity.
  • Current understanding of fluoride's mechanisms is insufficient.

Purpose of the Study:

  • To elucidate the mechanisms behind sodium fluoride's skeletal effects.
  • To guide the therapeutic modification of fluoride use.
  • To differentiate beneficial from detrimental effects.

Main Methods:

  • Review of existing clinical investigations.
  • Analysis of pharmacological actions on bone.
  • Examination of toxicological profiles.

Related Experiment Videos

Main Results:

  • Sodium fluoride exhibits significant, dual effects on bone.
  • Beneficial and toxic actions are intrinsically linked.
  • Clinical data spans over thirty years.

Conclusions:

  • Further mechanistic studies are essential for safe fluoride therapy.
  • Optimizing fluoride's therapeutic ratio requires deeper understanding.
  • Sodium fluoride's current clinical role is limited to research settings.